Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)

NCT04165486 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: ION464
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.